Zymeworks Inc.
ZYME- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937653
No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Zymeworks Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −7 vs. Q3 2021
- Shares held
- 42.3M
- +5.53M (+15.0%) vs. Q3 2021
- Total value
- $693.9M
- −$374.9M (−35.1%) vs. Q3 2021
- New holders
- 22
- 43 more added
- Sold out
- 29
- 26 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZYME on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $1.79B |
| Q1 2026 | 212 | $1.76B |
| Q4 2025 | 210 | $1.88B |
| Q3 2025 | 184 | $1.26B |
| Q2 2025 | 182 | $949.0M |
| Q1 2025 | 186 | $840.9M |
| Q4 2024 | 174 | $973.2M |
| Q3 2024 | 163 | $834.7M |
| Q2 2024 | 164 | $580.6M |
| Q1 2024 | 171 | $713.0M |
| Q4 2023 | 157 | $674.0M |
| Q3 2023 | 140 | $395.5M |
| Q2 2023 | 137 | $547.9M |
| Q1 2023 | 116 | $512.6M |
| Q4 2022 | 96 | $449.9M |
| Q3 2022 | 91 | $293.7M |
| Q2 2022 | 114 | $253.3M |
| Q1 2022 | 120 | $327.3M |
| Q4 2021 | 114 | $693.9M |
| Q3 2021 | 123 | $1.07B |
| Q2 2021 | 109 | $1.20B |
| Q1 2021 | 125 | $1.12B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Zymeworks Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,250,197 | $20.5M | 0.50% | −1,273,803−50.5% | Reduced |
| Franklin Resources Inc | 1,257,090 | $20.6M | 0.01% | +560.0% | Added |
| Woodline Partners LP | 1,258,401 | $20.6M | 0.30% | +1,258,401 | New |
| Baker Bros. Advisors LP | 1,708,472 | $28.0M | 0.14% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,714,905 | $28.1M | 0.00% | +17,592+1.0% | Added |
| Morgan Stanley | 2,114,572 | $34.7M | 0.00% | −181,850−7.9% | Reduced |
| Credit Suisse AG | 2,463,975 | $40.4M | 0.03% | +117,457+5.0% | Added |
| Goldman Sachs Group Inc | 2,519,008 | $41.3M | 0.01% | +2,240,800+805.4% | Added |
| Bank of America Corp | 2,664,343 | $43.7M | 0.00% | +2,636,728+9,548.2% | Added |
| Eventide Asset Management, LLC | 2,819,135 | $46.2M | 0.59% | −910,054−24.4% | Reduced |
| Wellington Management Group LLP | 2,856,986 | $46.8M | 0.01% | +2,257,851+376.9% | Added |
| FMR LLC | 3,491,547 | $57.2M | 0.00% | +12,618+0.4% | Added |
| Perceptive Advisors LLC | 3,679,845 | $60.3M | 0.93% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 18 | – | – | +18 | New |
| Pictet Asset Management SA | 0 | $0 | 0.00% | −1,767,508−100.0% | Sold out |
| Lone Pine Capital LLCSuperinvestorLone Pine Capital | 0 | $0 | 0.00% | −976,735−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −73,200−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −56,851−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −49,992−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −38,814−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −38,784−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −33,841−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −33,737−100.0% | Sold out |
| K.J. Harrison & Partners Inc | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −21,133−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,532−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −17,977−100.0% | Sold out |
| Silphium Asset Management Ltd | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −13,894−100.0% | Sold out |
| Vigilare Wealth Management | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −10,060−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −9,871−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −9,490−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| 1623 Capital LLC | 0 | $0 | 0.00% | −7,724−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −7,072−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −6,100−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,306−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Consolidated Planning Corp | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| Knott David M | – | – | – | – | Not filed |